MAPT and Alzheimer disease: In contrast, we predicted that the examined AD biomarkers would not contribute to individual differences in memory performance, based on our previous work (Alm et al., 2020) that found CSF markers of Aβ42 and total tau (t-tau), as well as medial temporal lobe gray matter volumes, were not significantly associated with delayed episodic memory performance in cognitively normal older adults.